St George’s Hospital, London has just opened a study that is looking at adding an immunotherapy (IMM-101) to nivolumab for advanced melanoma.

The study is enrolling 2 groups of patients – 18 patients who haven’t had treatment for advanced melanoma and 8 patients whose advanced melanoma got worse during previous immunotherapy treatment

Please see for further information, contacts and the main entry conditions.

Any patients who need further information, please contact your treating team, or let us know how we can help